TOPIRAMATE ER 50 MG CAPSULE

Topiramate
$5.9222per EA

Strength

50 mg/1

Manufacturer

Endo USA Inc.

NDC

10370036611

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA205976

On Market Since

5/26/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+2.2%

3M

-11.1%

6M

-8.3%

1Y

-17.1%

3Y

N/A

5Y

N/A

All

-52.4%